NEWS
Latest News & Press
July 24, 2026
Canopy Growth to Report First Quarter Fiscal 2027 Financial Results on August 7, 2026
SMITHS FALLS, ON – July 24, 2026 – Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX: WEED) (Nasdaq: CGC) will release its financial results for the first quarter fiscal year 2027 ended June 30, 2026 before financial markets open on August 7, 2026.
July 21, 2026
Canopy Growth Announces Participation at Upcoming Canaccord Genuity Growth Conference
SMITHS FALLS, ON – July 21, 2026 – Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX: WEED) (Nasdaq: CGC) announced it will be participating at the Canaccord Genuity Growth Conference in August 2026.
June 16, 2026
Medical cannabis: the driving force behind Canopy Growth’s recovery
By Aurélien BERNARD
Canadian cannabis producer Canopy Growth announced a significant improvement in its financial results for the fourth quarter of fiscal year 2026, driven by strong growth in both the medical cannabis sector and its international operations. These results suggest that the restructuring efforts the company has been undertaking for several years may finally be starting to pay off.
June 15, 2026
Canopy Growth Reports Fourth Quarter and Fiscal Year 2026 Financial Results; Delivers Q4 FY2026 Net Revenue Growth of 27% in Canada Medical and 68% in International Markets Cannabis
Full-year 2026 growth driven by net revenue increases of 20% in Canada adult-use cannabis and 18% in Canada medical Completed acquisition of MTL Cannabis, positioning Canopy Growth as Canada’s leading medical cannabis company by revenue Ended the fiscal year with $131.3M of net cash following strategic recapitalization completed in January 2026 Strategic decisions and financial